Psychedelic Stocks Archives - Page 17 of 61

WednesdayNov 08, 2023 11:59 am

Treat California Pulls Plug on 2024 Psychedelic Legalization Drive

A campaign that was working to legalize psychedelics in California has suspended its efforts to get a psychedelic legalization initiative on the 2024 ballot. Treat California is a citizen-driven ballot measure that would have funded the research and development of psychedelic medicines in California. The campaign recently announced that it is pulling out of the signature-gathering process and will be focusing its attention on a recently founded nonprofit organization committed to improving mental health and well-being. Although Californian voters have expressed major support for legalizing psychedelic research and expanding the public’s access to psychedelic-assisted treatments, recent surveys show that a…

TuesdayNov 07, 2023 3:53 pm

Regular Attendance of Ayahuasca Ceremonies Improves Well-Being, Study Concludes

Individuals who take part in ayahuasca ceremonies regularly reported fewer chronic and lifestyle-related diseases, increased physical activity, better diets and improved well-being compared to the general population. A recent study from the Netherlands has found that regular ayahuasca ceremony participants had better stats in various aspects of their physical and emotional lives compared to nonayahuasca users, indicating that the psychedelic may have some benefits to regular users. Ayahuasca is a traditional psychedelic brew that has been historically used by Indigenous Amazonian communities for religious, healing and spiritual purposes. Ayahuasca is created by combining a vine called Banisteriopsis caapi with leaves…

MondayNov 06, 2023 2:34 pm

Researchers Find That Psychedelics Users Embrace Alternative Viewpoints

Researchers have found that there may be a “clear association” between psychedelic use and embracing alternative viewpoints. Intent on determining whether exposure to psychedelics made people more likely to affirm alternative views, the research team provided a Conspiracy Mentality Questionnaire to nearly 400 participants who had taken part in a prior poll on the potential associations between schizotypy and psychedelic use. Schizotypy refers to personality traits with mild characteristics that are similar to schizophrenia symptoms, such as unusual behaviors and beliefs. According to the survey, 233 of the 392 study participants had recently used classic psychedelics such as LSD, psilocybin…

FridayNov 03, 2023 1:37 pm

DEA Announces Major Increase to 2023 Production Quotas for Psilocybin, THC and Ibogaine

The U.S. Drug Enforcement Administration (DEA) is proposing a “dramatic increase” in this year’s production quotas for psychedelics ibogaine and psilocybin as well as marijuana compound delta-9 THC to “support research and clinical trials.” According to the proposal, the DEA would like to almost double its THC, psilocybin and psilocin production compared to its origin projections for 2023 and increase ibogaine production by four times. The federal agency said in a recently published notice that it wants to increase “other tetrahydrocannabinol” production from 15,000 grams to 350,000 grams, raising the quota by a whopping 23 times. It also wants to…

ThursdayNov 02, 2023 2:49 pm

Psychedelic Advocates Say They Have Enough Signatures for Legislative Action

Supporters of a campaign to legalize psychedelics in Massachusetts believe they have gathered enough signatures to compel legislators to consider their initiative. If this is not successful, the group plans to put the psychedelics legalization measure on next year’s ballot. This move comes less than two months after the group, called Massachusetts for Mental Health Options, started its petition. The campaign, which is backed by New Approach, has revealed that it has verified more than 75,000 signatures from registered voters in the state. This milestone comes weeks after activists decided to pursue one of the pair of psychedelic initiatives the…

TuesdayOct 31, 2023 2:44 pm

Seattle Doctor Scores Court Win Against DEA Over Refusal to Reschedule Psilocybin

Last week, a federal appeals court ruled against the U.S. Drug Enforcement Agency (DEA) in a lawsuit filed by a doctor in Washington state who sought to get psilocybin rescheduled. The U.S. Court of Appeals for the Ninth Circuit stated that the agency hadn’t explained its reasoning when it denied Dr. Sunil Aggarwal’s petition, and the court ordered the DEA to provide a more complete justification. In its letter of denial, the DEA stated that a precondition to transferring a substance from Schedule I to II under the Controlled Substance Act was for the U.S. Food and Drug Administration (FDA)…

MondayOct 30, 2023 11:55 am

Study Suggests Methamphetamine More Helpful for Social Bonding Compared to MDMA

A recent study on methamphetamines and MDMA has produced interesting findings on the two drugs and their potential association with human connection. Researchers found that both MDMA and methamphetamines can enhance feelings of closeness and connectedness, but methamphetamines seemed to deliver stronger long-term benefits on social bonding compared to the psychedelic. While both methamphetamines and MDMA are psychoactive in nature, they affect people in wildly different ways. MDMA (also known as molly or ecstasy) is a hallucinogenic with prosocial and empathogenic properties. MDMA users often report increased feelings of emotional closeness and trust, which has led to increased MDMA use…

FridayOct 27, 2023 12:10 pm

Study Shows Ketamine Acts Against TRD within Four Hours

Researchers from Sorbonne University have found that ketamine can reduce depression symptoms in patients with treatment-resistant depression (TRD) just four hours after infusion. Compared to healthy controls, patients with TRD reported feeling more optimistic a few hours after ketamine infusion, indicating that the psychedelic may have potent and fast-acting mental health benefits. Prior studies have suggested that ketamine can alleviate depressive symptoms and reduce suicidal thoughts in some people, but this recent study sought to understand exactly how ketamine delivered its antidepression effects. Hugo Bottemanne from Sorbonne University’s Paris Brain Institute said several pharmacological studies have shown ketamine has the…

ThursdayOct 26, 2023 3:55 pm

Study Suggests Psilocybin Could Manage Childhood Trauma

A recent Canadian study has suggested that psilocybin, the main hallucinogenic agent in magic mushrooms, may ease the psychological distress associated with childhood trauma. Researchers say the psychedelic seemed to offer “particularly strong benefits” to individuals who faced extremely severe adversity during childhood. Led by a team of researchers from Athabasca University, the University of British Columbia, Simon Fraser University and the University of Michigan, the study involved assessing the childhood trauma experiences of 1,249 Canadians aged 15 years and older. The researchers asked participants about any prior psilocybin use, when they last took the psychedelic and the strength and…

WednesdayOct 25, 2023 1:19 pm

Hearings Commence for Lawsuit Denying Psilocybin Scheduling Change Request

A federal appeals court panel has begun hearing arguments in a case involving a Seattle doctor who sued the U.S. Drug Enforcement Administration for denying his patients access to psilocybin therapy and who is now asking the federal government to reschedule the psychedelic. The suit is part of the Seattle-based doctor’s efforts to expand psilocybin access to terminally ill patients to treat anxiety and end-of-life depression. Psychedelics such as psilocybin, or magic mushrooms, are all the rage these days thanks to a growing body of research indicating they have potent mental health benefits. Dr. Sunil Aggarwal wanted to use psilocybin,…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks